Recent Publications

• Alali J, Ramji A, Ho JK, Scudamore CH, Erb SR, Cheung E, Kopit B, Bannon CA, Dhung SW, Soos JG, Buczkowski AK, Brooks EM, Steinbrecher UP, Yoshida EM.  Liver Transplant Candidate Unsuitability: A Review of the BC Experience.  Canadian Journal of Gastroenterology. 2006; 20: 95-99.
• Apiratpracha W, Ho JK, Powell JJ, Yoshida EM. Acute Lower Gastrointestinal Bleeding from a Dieulafoy Lesion in the Rectum Just Proximal to the Ano-Rectal Junction Post-Orthotopic Liver Transplant. World Journal of Gastroenterology 2006; 14: 7547-7578.
• Bain VG, Kaita K, Yoshida EM, Swain M, Heathcote J, Newmann AU, Fiscella M, Yu R, Osborn B, Cronin PA, Freimuth WW, McHutchinson JG, Subramanian GM.  A Phase 2 Study to Evaluate the Antiviral Activity Safety and Pharmacokinetics of Albuferon Recombinant Human Albumin-Inteferon alpha Fusion Protein in Genotype ! Chronic Hepatitis C Patients.  Journal of Hepatology 2006; 44: 671-78.
• Bain VG, Yoshida EM, Kaita KD, Swain MG, Heathcote EJ, Garcia A, Moore PA, Yu R, McHutchinson JG, Subramanian GM. Pharmacodynamics of Albumin-Interferon alfa Assessed by Induction of Interferon Specific Gene Expression in Peripheral Blood in a Phase 2a Study in INF alfa Naive Patients with Genotype 1 Chonic Hepatitis C Infection. Hepatology Research 2006; 35: 256-262.
• Cantarovich M, Yoshida EM, Marotta PJ, Greig PD, Kneteman NM, Marleau D, Peltekian KK, Barkun J.  Poor Prediction of the Glomerular Filtration Rate Using Current Formulae in De Novo Liver Transplant Patients.  Transplantation 2006; 82: 433-36.
• Cheung J, Wong W, Zandieh I, Leung Y, Lee SS, Ramji A, Yoshida EM.  Acute Management and Secondary Prophylaxis of Esophageal Variceal Bleeding: a Western Canadian Study. Canadian Journal of Gastroenterology 2006; 20: 531-34.
• Ho JK, Harrigan PR, Sherlock CH, Steinbrecher UP, Erb SR, Mo T, Chung SW, Buczkowski AK, Intaraprasong P, Scudamore CH, Yoshida EM. Utilization of a liver allograft from a hepatitis B surface antigen positive donor. Transplantation. 2006;81:129-131.
• Ho JK, Ko HH, Schaeffer DF, Erb SR, Wong C, Buczkowski AK, Chung SW, Scudamore CH, Steinbrecher UP, Yoshida EM. Sexual Health after Orthotopic Liver Transplantation. Liver Transplantation 2006; 12: 1478-1484.
• Ho JK, Yoshida EM.  Extra-hepatic Consequences of Cirrhosis.  Medscape General Medicine 2006; 8:59 (8 pages) (E Journal; www.medscape.com) (Invited article subjected to peer-review).
• Ko H, Yoshida EM. Acute fatty liver of pregnancy. Can J Gastroenterol. 2006;20:25-30.
• Law JK, Ali JA, Harrigan PR, Sherlock CH, Savage K, Yoshida EM. Fatal Post-Lymphoma Chemotherapy Hepatitis B Reactivation Secondary to the Emergence of a YMDD Mutation Viral Strain with Lamivudine Resistance. American Journal of Hematology 2006; 81: 969-972.
• Lee SS, Bain VG, Peltekian K, Krajden M, Yoshida EM, Deschenes M, Heathcote J, Bailey RJ, Simonyi S, Sherman M. Treating chronic hepatitis C with pegylated interferon alfa-2a (40 KD) and ribavirin in clinical practice. Aliment Pharmacol Ther. 2006;23:397-408.
• Leung Y, Ip Chan J, Yoshida EM, Wu HX, Daly PC.  A Cross-Sectional Analysis of Acute Hepatitis B Reported to the Vancouver Coastal Health Authority 2000-2003.  Canadian Journal of Gastroenterology 2006; 20: 471-74.
• Powell JJ, Apiratpracha W, Partovi N, Erb SR, Scudamore CH, Steinbrecher UP, Buczkowski AK, Chung SW, Yoshida EM. Subcutaneous Administration of Hepatitis B Immune Globulin (HBIG) in Combination with Lamivudine Following Orthotopic Liver Transplantation: Effective Prophylaxis Against Recurrence. Clinical Transplantation 2006; 20:524-25.
• Ramji A, Yoshida EM, Kwan WCP.  Durability of Lamivudine Associated HBe Antigen Seroconversion in Chinese-Canadian Patients with Chronic Hepatitis B Virus Infection.  Internet Journal of Gastroenterology 2006; 4 (E-jounal @ www.ispub.com).
• Shah J, Yoshida EM, Connors J, Gill S. Hepatic Dysfunction During and After Lymphoma Chemotherapy in Patients with Hepatitis C. Journal of Clinical Gastroenterology 2006; 40: 636-38.
• Sherman M, Yoshida EM, Deschenes M, Krajden M, Bain V, Peltekian K, Anderson F, Kaita K, Simonyi S, Lee SS.  Peginterferon alfa-2a (40KD) (Pegasys) plus ribavirin (Copegus) in chronic hepatitis C patients who failed previous interferon therapy: results of a multicentre open-label access program in Canada.  Gut  2006; 55: 1631-1638.
• Tremlett H, Seemuller S, Zhao Y, Yoshida EM, Petkau J, Oger J. Liver Test Abnormalities in Multiple Sclerosis. Neurology 2006; 67: 1291-1293.
• Wang CS, Ko HH, Yoshida EM, Marra C, Richardson K. The Efficacy of Interferon-Based Combination Anti-Viral Therapy for Hepatitis C Virus After Liver Transplantation: A Meta-Analysis. American Journal of Transplantation 2006; 6: 1586-99.
• Yoshida EM, Reilly M, Arbour LT. Autoimmune Liver Disease in Canadian First Nations Aboriginal Communities of British Columbia’s Pacific NorthWest. World Journal of Gastroenterology 2006; 12: 3625-27 (Invited Article subjected to peer-review).
• Zandieh I, Adenwalla M, Cheong-Lee C, Ma PE, Yoshida EM. Retinal Vein Thrombosis Associated with Combination Peginterferon and Ribavirin Therapy for Chronic Hepatitis C. World Journal of Gastroenterology 2006; 12: 4908-10.
• Buczkowski AK, Schaeffer DF, AlKattan, Ho JK, Yoshida EM, Steinbrecher UP, Erb S, Chung SW, Scudamore CH.  Spatulated End-to-End Bile Duct Reconstruction in Liver Transplantation Reduces Biliary Complications and Further Procedures.  Clinical Transplantation 2007; 21: 7-12.
• Fasial Saleh, Hin Hin Ko, Jenny Davis, Wichian Apiratpracha, James J. Powell, Eric M. Yoshida. Fatal Hepatitis C after Cyclophosphamide and Corticosteroid Treatment Therapy. Annals of Hepatology 2007; 6: 186-89.
• Henry V. Chung, Mark Riley, Jin Kee Ho, Benjamin Leung, Gareth P. Jevon, Laura Arbour, Richard Schreiber, Eric M. Yoshida. Retrospective Review of Pediatric and Adult Autoimmune Hepatitis in Two Quaternary Care Centres in British Columbia: Increased Prevalence Seen in BC’s  First Nations Communities. Canadian Journal of Gastroenterology 2007; 21: 565-58.
• Hin Hin Ko, Eric M. Yoshida. Salud i. Ciencia. La Fibrosis Hepatica Puede Revertirse Con El Tratamiento Adecuado (Regression of Cirrhosis).  April 30, 2007 (www.siicsalud.com) (Invited Article subjected to peer-review process; translated into Spanish by journal Editors).
• Ian Cadden, Nilufar Partovi, Eric M. Yoshida. Possible Beneficial Effects of Coffee on Liver Disease and Function.  Good News for the Starbucks Generation?: An Indepth Review. Alimentary Pharmacology and Therapeutics 2007; 26: 1-8.
• Janakie Singham, David Schaeffer, Eric. M. Yoshida, Charles H. Scudamore. Choledochal Cysts:  Analysis of Disease Pattern and Optimal Treatment in Adult and Paediatric Patients. HPB: The Official Journal of the International Hepato Pancreato Biliary Association. 2007; 9: 383-87.
• Jin Kee Ho, Nasim Mahmoudi, Jaber Alali, Eric M. Yoshida, Michael F. Byrne. Duodenal Varices: A Rare Manifestation of Portal Hypertension. Internet Journal of Gastroenterology 2007; 5 (E-journal @ www.ispub.com).
• Koleba T, Yoshida EM, Partovi N. North American and European Health Care Workers Traveling to Countries Highly Endemic for Hepatitis A: Information and Recommendations. Internet Journal of Gastroenterology 2007; 5 (E-journal @ www.ispub.com).
• Peter T.W. Kim, Jenny E. Davis, Siegfried R. Erb, Eric M. Yoshida, Urs P. Steinbrecher. Colonic Malakoplakia in a Liver Transplant Recipient. Canadian Journal of Gastroenterology 2007; 21: 753-55.
• Pongphob Intaraprasong, Kirin Assi, David A. Owen, David G. Huntsman, Stephen W. Chung, Charles H. Scudamore, Eric M. Yoshida, Baljinder Salh. Expression of Integrin-linked Kinase is not a Useful Prognostic Marker in Resected Hepatocellular Cancer Anti-Cancer Research 2007; 27: 4371-76.
• Santos AD, Partovi N, Ford JE, Yoshida EM. A Review of Anemia and Neutropenia in the Treatment of Chronic Hepatitis C with PegInteferon & Ribavirin Combination Therapy and the Use of Hematologic Growth Factors as Adjuvant Therapy. Annals of Pharmacotherapy 2007; 41: 268-75.
• C.L. Cooper, R.J. Bailey, V.G. Bain, F. Anderson, E.M. Yoshida, M. Krajden, P. Marotta. Outcomes with Peginterferon alfa-2a & Ribavirin Hepatitis C Therapy in First Nations Canadian. Canadian Journal of Gastroenterology 2008; 22:677-80.
• Carmine G. Nudo, Eric M. Yoshida, Vincent G. Bain, Denis Marleau, Phillip Wong,  Paul J. Marotta, Eberhardt Renner, Kymberly D. Watt, Marc Deschenes. Liver Transplantation for Hepatic Epithelioid Hemangioendothelioma: The Canadian Multicenter Experience. Canadian Journal of Gastroenterology 2008; 22: 821-24.
• Hin Hin Ko, Erica Greanya, Tim K. Lee, Urs P. Steinbrecher, Siegfried R. Erb, Eric M. Yoshida. Mycophenolate Mofetil in Liver Transplant Patients with Calcineurin-Inhibitor Induced Renal Impairment. Annals of Hepatology 2008; 7: 376-80.
• Holly A.R. Wiesinger, Justin Shah, Adam White, Eric M. Yoshida, Jiri Frolich, Sandra Sirrs, Sabrina Gill, Michael F. Byrne. Liver Biochemistry Abnormalities in a Quaternary Care Lipid Clinic Database. Annals of Hepatology 2008; 7: 63-66.
• Iman Zandieh, Darin Krygier, Victor Wong, John Howard, Lawrence Worobetz, Gerald Minuk, Helga Witt-Sullivan, Eric. M. Yoshida. The Use of Budesonide in the Treatment of Autoimmune Hepatitis in Canada: the Canadian Experience. Canadian Journal of Gastroenterology 2008; 22: 388-92.
• “Jeff Powis, Kevork Peltekian, Samuel S. Lee, Morris Sherman, Vincent G. Bain, Curtis Cooper, Mel Krajden, Robert F. Balshaw, E. Jenny Heathcote, Eric M. Yoshida.
• Differential Treatment Effect of Peginterferon Alpha 2a (Pegasys) and Ribavirin Combination Therapy on Genotype 2 vs. Genotype 3. Journal of Viral Hepatitis 2008; 15: 52-57.”
• K.D. S. Watt, K. Burak, M. Deschenes, L. Lilly, D. Marleau, P. Marotta, A. Mason, K.M. Peltekian, E.L Renner, E.M. Yoshida. Survival after Liver Transplantation for Hepatitis C is Unchanged over the Recent Years in Canada. Canadian Journal of Gastroenterology 2008; 22: 153-54.
• Karen I. Kroeker, Vincent G. Bain, Thomas Shaw-Stiffel, Tse-Ling Fong, Eric M. Yoshida. Adult Liver Transplant Survey: Policies towards Eligibility Criteria in Canada and the United States 2007. Liver International 2008; 28: 1250-55.
• Kelly A. Grindrod, Eric M. Yoshida, Nilu Partovi. Questioning the Role of Routine Liver Enzyme Monitoring in Long-term Statin Therapy. Canadian Pharmacists Journal 2008; 141 Suppl 2: S21-22  (Invited article subjected to peer review process).
• Michael A. Heneghan, Markus Selzner, Eric M. Yoshida, Beat Mullhaupt. Pregnancy and Sexual Function in Liver Transplantation. Journal of Hepatology (invited article, 11th Transplantation Forum, subjected to peer review process) 2008: 49: 507-19.
• Myriam Farah, Abdel Alrashidi, David A. Owen, Eric M. Yoshida, Graham Reid. Granulomatous Hepatitis and Etanercept Therapy. Journal of Rheumatology 2008; 35: 349-51.
• “Paul R. Yenson, Eric. M. Yoshida, Charles H. Li, Henry V. Chung, Peter W.K. Tsang.
• Hyperferritinemia in the Chinese and Asian Community: A Retrospective Review of the University of British Columbia Experience. Canadian Journal of Gastroenterology 2008; 22: 37-40.”
• Penny Bring, Nilu Partovi, Jo-Ann Ford, Eric M. Yoshida. A Review of Iron Overload Disorders: Treatment Options for Patients Unable to Use Phlebotomy. Pharmacotherapy 2008; 28: 331-42.
• Shaila Merchant, Eric M. Yoshida, Tim K. Lee, Penny Richardson, Kari Karlsberg, Elsie Cheung. Exploring the Psychological Effect of Cadaveric Organ Donation on the Families of the Organ Donors of British Columbia, Canada. Clinical Transplantation 2008; 22: 341-47.
• Stefan Zeuzem, Eric M. Yoshida, Yves Benhamou, Stephen Piako, Vincent G. Bain, Daniel Shouval, Robert Flisiak, Vratislav Rehak, Mircea Grigorescu, Kelly Kaita, Patrick A. Cronin, Erik Pulkstenis, G. Mani Subramanian, John G. McHutchison. Phase 2b Results of Albinterferon alfa 2b Dosing Every 2 or 4 Weeks in Genotype 1, Interferon Naïve Chronic Hepatitis C Patients. Hepatology 2008; 48: 407-17.
• Vince G. Bain, Kelly D. Kaita, Paul Marotta, Eric. M. Yoshida, Mark G Swain, Robert Bailey, Keyor Patel, Patrick W. Cronin, Erik Pulkstenis, G. Mani Subramanian. Albinterferon alfa 2-b dosed at 4-week intervals is safe and demonstrates significant antiviral activity in genotype 2 or 3, chronic hepatitis C virus: results of a phase 2 study. Clinical Gastroenterology and Hepatology 2008; 6: 701-06.
• Vincent G. Bain, Samel S. Lee, Kevork Peltekian, Eric M. Yoshida, Marc Deschenes, Morris Sherman, Robert Bailey, Helga Witt-Sullivan, Robert Balshaw, Mel Krajden. Exposure to Ribavirin Predicts EVR and SVR in Patients with HCV Genotype 1 Infection Treated with Peginteferon alfa-2a plus Ribavirin. Alimentary Pharmacology and Therapeutics 2008; 28: 43-50.
• Wichian Apiratpracha, Eric. M. Yoshida, Charles H. Scudamore, Alan A. Weiss, Michael F. Byrne. Chronic Pancreatitis: A Previously Unreported Sequelae of Acute Fatty Liver of Pregnancy. Hepatobiliary and Pancreatic Diseases International 2008; 7: 101-104.
• Buresi M, Zandiah I, Nagy A, Weiss AA, Yee WC, Spielman A, Yoshida EM. The Use of Endoscopic Ultrasonography (EUS) and Magnetic Resonance Imaging (MRI) in the Preoperative Staging of Rectal Villous Tumors: a Case of Overstaging by Magnetic Resonance Imaging (MRI). Canadian Journal of Gastroenterology 2009; 9: 639-41.
• Cadden ISH, Greanya ED, Erb SR, Scudamore CH, Yoshida EM. The Use of Sildenafil to Treat Portopulmonary Hypertension Prior to Liver Transplantation. Annals of Hepatology 2009; 8: 158-61.
• Chang A, Krygier DS, Chatur N, Yoshida EM. Clozapine-Induced Fulminant Hepatic Failure: A Case Report. Canadian Journal of Gastroenterology 2009; 23: 376-78.
• Chung, C.  Ali, JA., Owen, D., Weiss, A., Yoshida, E., Tai, I.  A Rare Case of Isolated Duodenal Metastases from Hepatocellular Carcinoma Associated with p53 and ki67 Expression: a Case Report.   Cases Journal 2009; 2: 9344 (www.casesjournal.com).
• Haque, M., Schumacher, PA., Harris, A., Scudamore, CH., Steinbrecher, UP., Chung, SW., Buczkowshi, AK., Erb, SR., Yoshida, EM.  Late Acute Celiac and Hepatic Artery Thrombosis with Portal Vein Thrombosis Resulting in Hepatic Infaction 12 years Post-Orthotopic Liver Transplantation.  Annals of Hepatology 2009; 8: 396-99.
• Hsu PC, Krajden M,  Yoshida EM, Anderson FH, Tomlinson G, Krahn MD. Does Cirrhosis Affect Quality of Life in Hepatitis C-Virus Infected Patients?. Liver International. 2009; 29: 449-58.
• John-Baptiste A, Tomlinson G, Hsu P, Krajden M, Heathcote J, Laporte A, Yoshida E, Anderson F, Krahn M. Quality of Life and Productivity Following Anti-Viral Therapy for Chronic Hepatitis C Virus Infection. American Journal of Gastroenterology 2009; 104: 243-48.
• Krygier, DS., Steingbrecher, UP., Petric, M., Erb, SR., Chung, SW., Buzchowski, AK.  Parvovirus B19 induced hepatic failure in an adult requiring liver transplantation.  World J Gastroenterol 2009; 15: 4067-4069.
• Law JK, Salh B, Yoshida EM. All that Bleeds is not Infliximab-refractory Ulcerative Colitis. Canadian Journal of Gastroenterology 2009; 23: 91-92.
• Neumann AU, Patel K, Bain VG, Yoshida EM, Subramanian GM. Early Prediction of SVR at Day 3 of Treatment with Albinterferon alfa-2b in Patients with Hepatitis C Genotype 2,3 Infection. Liver International 2009; 29: 1350-55.
• Neumann AU, Pianko S, Zeuzem S, Yoshida EM, Benhamou Y, Mishan M, McHutchinson JG, Pulkstenis E, Subramanian GM. Positive and Negative Prediction of Sustained Virologic Response at Week 2 and 4of treatment with Albinterferon alfa-2b or Peginterferon alfa 2-a  in Treatmen-Naïve Patients with Genotype 1, Chronic Hepatitis C. Journal of Hepatology  2009; 51: 21-28.
• Patel K, Benhamou Y, Yoshida EM, Kaita KD, Zeuzem S, Torbensen M, Pulkstenis E, Mani Subramanian G, McHutchison JG. An Independent and Prospective Comparison of Two Commercial Fibrosis Marker Panels (FibroSURE and FIBROSpect II) During Albinterferon alfa-2b Combination Therapy for Chronic Hepatitis C. Journal of Viral Hepatitis. 2009; 16: 178-86.
• Phillips P, Lee JK,  Wang C, Yoshida E, Montaner J. Chylous Ascites: A Late Complication of Intraabdominal Mycobacterium Avium Complex Immune Reconstitution Syndrome in HIV-Infected Patients. International Journal of STD and AIDS 2009; 20: 285-87.
• Schaeffer DF, Yoshida EM, Buczkowski AL, Erb SR, Steinbrecher UP, Chung SW, Scudamore CH. Surgical Morbidity in Severely Obese Liver Transplant Recipients: A Single Centre Experience. Annals of Hepatology 2009; 8: 38-40.
• Singham J, Yoshida EM, Scudamore SH. Choledochal Cysts: A Comprehensive Review: A Three Part Comprehensive Review: Part I – A Review of Classification and Pathogenesis. Canadian Journal of Surgery 2009; 52: 434-40.
• Singham J, Yoshida EM, Scudamore SH. Choledochal Cysts: A Comprehensive Review: A Three Part Comprehensive Review: Part II – Diagnosis of Choledochal Cysts. Canadian Journal of Surgery 2009; 52: 506-11.
• Yoshida EM, Sherman M, Bain VG, Cooper CL, Deschenes M, Marotta PJ, Lee SS, Krajden M, Witt-Sullivan H,  Bailey RJ, Usaty C, Peltekian K. Re-Treatment with Peginterferon alfa-2a and Ribavirin in Patients with Chronic Hepatitis C who have Relapsed or not Responded to a First Course of Pegylated Interferon-Based Therapy. Canadian Journal of Gastroenterology  2009; 23: 180-84.
• AlNahdi N, Wiesinger H, Sutherland H, Yoshida EM. Recurrent Idiopathic Acute Hepatitis Associated Aplastic Anemia/Pancytopenia Fourteen Years After Initial Episode. Annals of Hepatology 2010: 9:468-70.
• Al-Sarraf AJ, Haque M, Pudek M, Yoshida EM. Central Pontine Myelinolysis Following Orthotopic Liver Transplantation – a Rare Complication. Clinical and Experimental Transplantation 2010; 8: 321-24.
• Buresi MC, Lee J, Gill S, Kong JM, Money DM, Yoshida EM. Prevalence of Glucose Abnormalities in Pregnant Women with Hepatitis C Virus Infection in British Columbia. Journal of Obstetrics and Gynecology Canada 2010; 32: 935-41.
• Deschenes M, Bain VG, Lee SS, Sherman M, Cooper CL, Yoshida EM, Marotta PJ, Krajden M, Ustaty C, Balshaw R, Peltekian K. Identifying HCV Genotype 1 Patients at Risk of Relapse. European Journal of Gastroenterology and Hepatology 2010: 22: 546-51.
• Haque M, Hashim A, Greanya ED, Steinbrecher UP, Erb SR, Yoshida EM. Spontaneous Clearance of Hepatitis C Infection Post-Liver Transplant: A Rare but Real Phenomenon?  A Case Report and Review of the Literature. Annals of Hepatology 2010; 9: 202-06.
• Haque M, Robinson C, Owen D, Yoshida EM, Harris A. Comparison of Acoustic Radiation Force Impulse Imaging (ARFI) to Liver Biopsy Histologic Scores in the Evaluation of Chronic Liver Disease. Annals of Hepatology 2010; 9: 289-93.
• Jiao M, Haque M, Greanya ED, Yoshida EM, Soos JG. Methadone Maintenance Therapy in Liver Transplantation. Progress in Transplantation 2010; 20: 209-14.
• Karim Z, Intaraprasong P, Scudamore CH, Erb SR, Soos JG, Cheung E, Cooper P, Buzckowski AK, Chung SW, Steinbrecher UP, Yoshida EM. Liver Transplantation in Patients with Alcohol Dependency: A Retrospective Analysis of Risk Factors for Recidivism. Canadian Journal of Gastroenterology 2010; 24: 245-50.
• Schumacher PA, Powell JJ, MacNeill AJ, Buczkowski AK, Erb SR, Ho SG, Scudamore CH, Steinbrecher UP, Weiss A, Yoshida E, Chung SW. Multimodal Therapy for Hepatocellular Carcinoma: a Complementary Approach to Liver Transplantation. Annals of Hepatology 2010; 9: 23-32.
• Singham J, Greanya E, Lau K, Erb SR, Partovi N, Yoshida EM. Efficacy of Maintenance Subcutaneous Hepatitis B Immune Globulin (HBIG) Post-Transplant for Prophylaxis Against Hepatitis B Recurrence. Annals of Hepatology 2010; 9: 166-171.
• Singham J, Yoshida EM, Scudamore CH. Choledochal Cysts: A Comprehensive Review: A Three Part Comprehensive Review: Part III – Management of Choledochal Cysts. Canadian Journal of Surgery 2010; 53: 51-56.
• Taddy H, Yoshida EM, Gibson G, Chatur N. Acetylcholine Receptor Antibody Positive Generalized Myasthenia Gravis in Association with Primary Biliary Cirrhosis. Annals of Hepatology 2010; 9: 471-72.
• Virk R, Gill S, Yoshida E, Radley S, Salh B. Racial Differences in the Incidence of Colorectal Cancer. Canadian Journal of Gastroenterology 2010; 24: 47-51.
• Blasig A, Wagner EC, Pi D, Bigham M, Remple V, Craib K, Doyle P, Dobson S, Yoshida EM, Patrick D, Krajden M, Money D. Hepatitis C Infection among Pregnant Women in British Colubmia: Reported Prevalence and Critical Appraisal of Current Prenatal Screening Methods. Canadian Journal of Public Health 2011; 102: 98-102.
• Brahmania M, Schwartz Z, Rosenfield G, Yoshida E. Sertraline Induced Hepatotoxicity: A Case Report and Review of Literature. Internet Journal of Gastroenterology 2011; 10 (www.ispub.com).
• Chan S, Kingwell E, Oger J, Yoshida E, Tremlett H. High-Dose Beta-Interferons Increase the Risk of Hepatocellular Liver Injury in Multiple Sclerosis: a Longitudinal Study. Multiple Sclerosis Journal 2011; 17: 361-62.
• Chen Y, Haque M, Yoshida EM. Transient Improvement of Acquired Hepatocerebral Degeneration with Parkinsonian Symptoms after Failed Liver Transplantation: A Case Report and Review of the Literature. Experimental and Clinical Transplantation 2011; 9: 363-69.
• Chin M, Levy RD, Yoshida E, Byrne M. Sitaxsentan-Induced Acute Severe Hepatitis Treated with Glucocorticoid Therapy. Canadian Respiratory Journal (In Press).
• Federico CA, Vuong PC, Krajden M, Yoshida EM, Weiss AA, Anderson FH, Krahn MD. Patient Time Costs and Out-of-Pocket Costs in Hepatitis C. Liver International 2011 (epub before print).
• Iman H, Yoshida E, Shojania K. Relapsing Polychondritis Associated with Hepatitis C. Clinical Rheumatology 2011 (epub before print).
• Jacobson IM, McHutchinson JG, Dusheiko G, Di Bisceglie A, Reddy R, Bzowej N, Marcellin P, Muir AJ, Ferenci P, Flisiak R, George J, Rizzetto M,  Shouval D, Sola R, Terg RA, Yoshida EM, Adda N, Bengtsson L, George S, Kauffman RS, Zeuzem  S. Teleprevir in Combination with Peginterferon and Ribavirin in Treatment-Naïve Patients with Genotype 1 Chronic Hepatitis C. New England Journal of Medicine 2011; 364: 2405-2416.
• Jacobson IM, McHutchinson JG, Dusheiko G, Di Bisceglie A, Reddy R, Bzowej N, Marcellin P, Muir AJ, Ferenci P, Flisiak R, George J, Rizzetto M, Shouval D, Sola R, Terg RA, Yoshida EM, Adda N, Bengtsson L, George S, Kauffman RS, Zeuzem S. Teleprevir in Combination with Peginterferon and Ribavirin in Treatment-Naïve Patients with Genotype 1 Chronic Hepatitis C. New England Journal of Medicine 2011; 364: 2405-2416.
• Kiang TKL, Ford J-A, Yoshida EM, Partovi N. Nitrofurantoin-Associated Lung and Liver Toxicity in a 57-year-old Female Requiring Liver Transplantation. Canadian Journal of Hospital Pharmacy 2011; 64: 262-270.
• Kim E, Ford J-A, Alkowaiter SS, Yoshida EM. Treatment of Hepatitis C Post-Transplant: Illustrative Case Report and Review of Current Literature of a Controversial Topic. Internet Journal of Gastroenterology 2011; 10 (www.ispub.com).
• Kim E, Ko HH, Yoshida EM. A Concise Review of Hepatitis C in Heart and Lung Transplantation. Canadian Journal of Gastroenterology 2011; 25: 445-48 (commissioned review, subject to peer review process).
• Kim E, Ko HH, Yoshida EM. Review of Treatment Issues Surrounding Hepatitis C in Renal Transplantation. Annals of Hepatology 2011; 10: 5-14.
• Lam MCW, Tha S, Haque M, Owen D, Chatur N, Gray JR, Yoshida EM. Gastric Polyps in Patients with Portal Hypertension. European Journal of Gastroenterology and Hepatology 2011; 23: 1245-49.
• Mangat B, Evaschen C, Owen DA, Lee T, Yoshida EM, Salh B. Ethnic Variation in the Annual Rates of Hospitalized Adult Inflammatory Bowel Disease Patients in Vancouver, Canada. Canadian Journal of Gastroenterology 2011; 25: 73-77.
• Nelson DR, Zeuzem S, Andreone P, Ferenci P, Herring R, Jensen DM, Marcellin P, Pockros P, Rodriguez-Torres M, Rossaro L, Rustgi VK, Sepe T,  Sulkowski M, Thomason IR, Yoshida E, Chan A, Hill G. Phase IIB Study of Balapiravir (RG1626; Nucleoside Analogue Inhi bitor of HCV Polymerase) plus Peginterferon Alfa-2A (40KD) and Ribavirin for Chronic Hepatitis C Genotype 1: Final Results. Alimentary Pharmacology and Therapeutics (tentatively accepted pending revisions).
• Pawlowska M, Yoshida EM, Collins D, Jones E. Life Threatening Gastrointestinal Hemorrhage and Perforation of the Small Intestine Secondary to Wegener’s Granulomatosis: a Case Report and Review of the Literature. Canadian Journal of General Internal Medicine 2011; 6: 143-45.
• Peltekian KM, Bain VG, Lee SS, Sherman M, Cooper CL, Yoshida EM, Marotta PJ, Krajdent M, Usaty C, Balshaw R, Deschenes M. Is Pre-Treatment Liver Biopsy Necessary in Patients with Chronic Hepatitis C Infections?  Pre-Treatment Liver Biopsy May be Necessary with Genotype 1 but not with Genotype 2 or 3. Annals of Hepatology 2011; 10: 260-69.
• Rastegar R, Hou D, Harris A, Yoshida EM, Lum B, Ho S, Ford J-A E, Chung SW, Soulez G, Liu D. Is a Liver Biopsy Necessary?  Investigation of a Suspected Hepatocellular Carcinoma: A Pictoral Essay of the Revised American Association for the Study of Liver (AASLD) Criteria. Canadian Association of Radiologists Journal 2011 (epub before print).
• Rosenfield GA, Chang A, Poulin M, Kwan P, Yoshida E. Cholestatic Jaundice, Acute Renal Failure and Acute Pancreatitsis Secondary to Methandrostenolone: A Case Report on an Adverse Outcome from Recreational Anabolic Steroid Use. Journal of Medical Case Reports 2011; 5: 138 (www.jmedicalcasereports.com).
• Schaffer D, Yoshida EM, Owen DA, Berean KW. The a priori  Diagnosis of familial adenomatous polyposis from the morphological features of a thyroid carcinoma. Case Reports in Medicine 2011: 767610 (doi: 10.1155/2011/767610).
• Wong JCT, Bressler B, Salh B, Yoshida EM, Chatur N. Consequence or Coincidence?  Development of Testicular Germ Cell Cancer Following Successful Infliximab Induction Therapy for Ulcerative Colitis. Journal of Crohn’s and Colitis 2011; 5: 162-64.
• Wong JCT, Robinson C, Jones ECJ, Harris A, Zwirewich C, Simons R, Wakefield R, Simons RK, Yoshida EM. Idiopathic No Longer.  Recurrent “Idiopathic” Pancreatitis  Over 30 Years Finally Diagnosed by MRCP and Cured by Surgical Resection of an Ectopic Pancreas in the Jejunum and Mesentery. Hepatobiliary and Pancreatic Diseases International 2011; 10: 218-20.
• Hsu P, Federico C, Krajden M, Yoshida EM, Anderson F, Weiss A, Krahn M. Health Utilities in Patients with Early-and Late-Stage Hepatitis C Virus Infection. Journal of Gastroenterology and Hepatology 2012: 27: 149-157.
• Nelson DR, Zeuzem S, Andreone P, Ferenci P, Herring R, Jensen DM, Marcellin P, Pockros P, Rodriguez-Torres M, Rossaro L, Rustgi VK, Sepe T, Sulkowski M, Thomason IR, Yoshida E, Chan A, Hill G. Phase IIB Study of Balapiravir (RG1626; Nucleoside Analogue Inhi bitor of HCV Polymerase) plus Peginterferon Alfa-2A (40KD) and Ribavirin for Chronic Hepatitis C Genotype 1: Final Results. Annals of Hepatology 2012: 11: 15-31.